P-21
P-21 Peptide
A nootropic peptide developed from cerebrolysin that enhances cognitive function, neurogenesis, and neuroplasticity.
Typical Cost
$80-150/vial (5mg)
Status
Research
Peptide Profile
P-21
Mechanism of Action
Promotes neurogenesis and synaptic plasticity. Enhances learning and memory formation. Supports neuronal repair and cognitive function.
Common Dosages
subcutaneous
100-300mcg
Daily · 4-8 weeks
intranasal
50-100mcg
Daily · 4-8 weeks
Benefits
Enhanced learning
Improved memory
Neurogenesis support
Better focus
Cognitive enhancement
Side Effects
Limited human data
Headache
Mild stimulation
Key Research
P-21 and cognitive enhancement
Demonstrated enhanced neurogenesis and cognitive function in animal models
Regulatory Status
Research chemical only. Not FDA-approved. Experimental nootropic.
Contraindications
- ⚠Pregnancy/breastfeeding
- ⚠Seizure disorders
GLP-1 users seeking cognitive enhancement may consider P-21 alongside SeraVia Energy+ Boost.
Learn More →Find peptide providers
Search 18,000+ clinics offering peptide therapy alongside GLP-1 medications.
Search Providers →Disclaimer: This information is for educational and research purposes only. Peptides described here may not be FDA-approved for human use. Always consult a qualified healthcare provider before using any peptide product. GLP1Search does not sell peptides.